Dgnv Islamabad standoff suspect Muhammad Sikandar sentenced to 16 years in prison
KARACHI:The rupee remained stable against the dollar at 104.4/104.6 in the inter-bank market on Friday compared to Thursday鈥檚 close of 104.4/104.6. The currency market has fluctuated regularly in recent months with hefty rises and falls on some occasions. In the long run, however, the rupee has stood firm after experiencing extensive volatility, when it weakened from arou adidas campus noir nd Rs98 to a dollar to above Rs10 adidas campus 00s 3 in the wake of pol new balance 996 itical impasse over alleged election rigging. Earlier, the rupee remained glued to the Rs98 level for months, recovering from the historic low of Rs110. It came under pressure following heavy debt repayments to the International Monetary Fund (IMF) and other creditors, which ate into the central bank鈥檚 foreign currency reserves. In 2013-14, the reserves, however, swelled more than 50%, thanks to IMF and other assistance and growing remittances sent home by overseas Pakistanis.Published in The Express Tribune, February 18th, 2017.Like聽Business on Facebook, follow @Tri Rosetta Genomicshas announced that it has signed a non-exclusive licensing agreement withRockefeller University for research application of proprietary microRNA genes. The agreement encompasses viral and human microRNAs that will be added to Rosetta Genomics' existing intellectual property (IP) estate, which includes two issued patents, two allowed patent application yeezy 350 s, and 60 pending patent applicatio dunk nike ns."As leaders in the microRNA field, we view our strong intellectual property position as a key component of our business stra nb sneakers 574 tegy, allowing us the freedom to advance the company and its pipeline." said Amir Avniel, President and CEO of Rosetta. "Our strategy continues to focus on supplementing our in-house IP portfolio with licensing agreements with key academic centers such as Rockefeller University."Rosetta Genomics has previously licensed Rockefeller University's proprietary microRNAs for therapeutic and diagnostic uses, and this recent agreement allows the company access to a full ra |
